Clinical Oncology Next Generation Sequencing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Clinical Oncology Next Generation Sequencing Market, By Technology

7.1.  Clinical Oncology Next Generation Sequencing Market, By Technology, 2020-2028

7.1.1.    Whole Genome Sequencing

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Whole Exome Sequencing

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Targeted Sequencing & Resequencing

7.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Clinical Oncology Next Generation Sequencing Market, By Application

8.1.  Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2028

8.1.1.    Screening

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Companion Diagnostics

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Others

8.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Clinical Oncology Next Generation Sequencing Market, By End User

9.1.  Clinical Oncology Next Generation Sequencing Market, by End User, 2020-2028

9.1.1.    Hospitals

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    Clinics

9.1.2.1.        Market Revenue and Forecast (2016-2028)

9.1.3.    Laboratories

9.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Clinical Oncology Next Generation Sequencing Market, By Workflow

10.1.        Clinical Oncology Next Generation Sequencing Market, By Workflow, 2020-2028

10.1.1.  NGS Pre-Sequencing

10.1.1.1.      Market Revenue and Forecast (2016-2028)

10.1.2.  NGS Sequencing

10.1.2.1.      Market Revenue and Forecast (2016-2028)

10.1.3.  NGS Data Analysis

10.1.3.1.      Market Revenue and Forecast (2016-2028)

Chapter 11.      Global Clinical Oncology Next Generation Sequencing Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.1.2.  Market Revenue and Forecast, by Application (2016-2028)

11.1.3.  Market Revenue and Forecast, by End User (2016-2028)

11.1.4.  Market Revenue and Forecast, By Workflow (2016-2028)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.1.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.1.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.1.5.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.1.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.1.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.1.6.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.2.2.  Market Revenue and Forecast, by Application (2016-2028)

11.2.3.  Market Revenue and Forecast, by End User (2016-2028)

11.2.4.  Market Revenue and Forecast, By Workflow (2016-2028)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.5.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.6.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.7.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.7.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.7.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.8.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.8.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.8.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.3.2.  Market Revenue and Forecast, by Application (2016-2028)

11.3.3.  Market Revenue and Forecast, by End User (2016-2028)

11.3.4.  Market Revenue and Forecast, By Workflow (2016-2028)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.5.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.6.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.7.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.7.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.7.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.8.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.8.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.8.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.4.2.  Market Revenue and Forecast, by Application (2016-2028)

11.4.3.  Market Revenue and Forecast, by End User (2016-2028)

11.4.4.  Market Revenue and Forecast, By Workflow (2016-2028)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.5.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.6.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.7.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.7.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.7.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.8.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.8.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.8.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.5.2.  Market Revenue and Forecast, by Application (2016-2028)

11.5.3.  Market Revenue and Forecast, by End User (2016-2028)

11.5.4.  Market Revenue and Forecast, By Workflow (2016-2028)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.5.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.5.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.5.5.4.      Market Revenue and Forecast, By Workflow (2016-2028)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.5.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.5.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.5.6.4.      Market Revenue and Forecast, By Workflow (2016-2028)

Chapter 12.  Company Profiles

12.1.              Agilent

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Thermo Fisher Scientific

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Myriad Genetics

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Beijing Genomics Institute (BGI)

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Perkin Elmer, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Qiagen NV

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Partek, Inc.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Pacific Bioscience, Inc.

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Foundation Medicine

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Oxford Nanopore Technologies Ltd.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Paradigm Diagnostics, Inc.

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           Caris Life Sciences

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           Eurofins Scientific

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms